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1 |  INTRODUCTION
As the spread of COVID-19 continues worldwide, a signifi-
cant number of pregnant women are getting infected and need 
care. This case describes a 27.4 weeks pregnant woman with 
critical COVID-19, treated with protective mechanical venti-
lation, prone positioning, and hyperimmune plasma. She was 
discharged with positive maternal and perinatal outcome.
As the number of patients with Coronavirus disease 2019 
(COVID-19) increases worldwide,1 many experimental or 
compassionate interventions have been considered,2 but their 
efficacy remains controversial in most of the cases.3 Both 
prone positioning, already in use in patients with severe acute 
respiratory distress syndrome (ARDS),4,5 and hyperimmune 
plasma therapy have been proposed for COVID-19.6,7
To date, limited reports have been published on the use 
of these treatments in pregnant women with COVID-19.8,9 
The use of experimental treatments in pregnant women 
often leads to concerns in both clinicians and researchers.10 
Nevertheless, COVID-19 infection in pregnancy leads to 
hospitalization for a significant proportion of women with 
10% requiring respiratory support and this number is ex-
pected to increase during the spread of the pandemic,11,12 
and interventions which have been proven effective are 
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position just because they are pregnant.
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urgently needed. The feasibility of prone positioning in 
pregnant women has already been described in literature,13 
in particular during the H1N1 pandemic.14 Similarly, spe-
cific contraindications against the use of hyperimmune 
plasma therapy in pregnant women are not reasonably 
expected.
Although we are still far from definitive confirmations 
of effectiveness and specific indications, here we report 
the case of a 34-year-old pregnant woman, at 27.4 weeks 
of gestation, admitted to our emergency department (ED) 
for critical COVID-19 and successfully treated in our insti-
tution. During her clinical course, clinical decisions were 
conducted by a multidisciplinary team. The patient was 
treated with protective ventilation, prone positioning, and 
hyperimmune plasma therapy, in addition to standard care. 
The patient was finally discharged home with no sequelae 
after a total length of stay (LOS) of 43  days and a suc-
cessful cesarean section (CS) delivery. This case report was 
prepared following the CARE Guidelines.15 The informed 
consent was obtained from the patient for the presentation 
of this case.
2 |  CASE PRESENTATION
A 34-year-old woman was admitted to the ED of “Ospedali 
Riuniti Villa Sofia-Cervello” Palermo, Italy, with dyspnea 
and tachypnea. The patient was 27.4 weeks pregnant, with no 
history of previous diseases, no allergies, two previous preg-
nancies with vaginal births and a previous appendectomy. At 
the interview, the patient reported a recent international flight 
and the onset of flu-like symptoms, with fever, asthenia, and 
musculoskeletal pain occurring few days after the flight and 
followed by a rapid clinical worsening. She reported no ben-
efit from paracetamol assumption. Physical examination 
showed decreased breath sounds to both lungs basis and arte-
rial blood gas (ABG) revealed severe respiratory failure, with 
SO2 70% and PaO2 38.9 mm Hg in room air (See Table 1).
Pulmonary embolism was suspected but rapidly excluded 
with the aid of cardiac ultrasound. Meanwhile, positivity to 
SARS-CoV-2 was detected from nasopharyngeal and oropha-
ryngeal swab specimens, that had been collected at the arrival 
to the ED and then analyzed. O2 therapy was started at 5 L/
min with a slight improvement. The patient was transferred 
to the COVID-19 pulmonology ward, where O2 flow was 
increased to 15  L/min. Noninvasive ventilation (NIV) was 
attempted without success, due to poor compliance to the in-
terface (face mask) and no improvements in respiratory fail-
ure. The patient was then admitted to the Intensive Care Unit 
(ICU), where high-flow nasal cannula (HFNC) oxygen ther-
apy was attempted (FiO2 between 80% and 90%; flow 60 lt/
min; temperature at 31°C), resulting in a slight improvement 
of oxygenation, even though tachypnea persisted. During the 
night, due to the worsening of respiratory failure, the patient 
was sedated, paralyzed, and intubated and invasive mechani-
cal ventilation was started with protective settings.
On hospitalization day (HD) 1, severe hypoxia persisted 
(P/F 64.4, SO2 87.7%). Thus, a multidisciplinary consulta-
tion was planned, involving neonatologists ad gynecolo-
gists. Given the early gestational age, the team decided to 
continue the pregnancy monitoring during ICU stay, and to 
perform a cesarean section delivery only in case of a drastic 
clinical worsening of either the mother or the child. It was 
also decided to attempt prone positioning, then successfully 
performed with the use of supports and pads beneath shoul-
ders and hips, to prevent aortocaval compression. The patient 
started a 12-hour daily cycle of pronation, and a progressive 
improvement of oxygenation was registered, allowing a FiO2 
decrease. The patient underwent a total of four cycles of pro-
nation, lasting 12 hours each. The last cycle was performed 
on HD 4, without consistent variations of respiratory param-
eters; therefore, no more cycles were performed.
Meanwhile, the ethics committee (“Comitato Etico 
Palermo 2”) gave the authorization to start a compassionate 
treatment with hyperimmune plasma, previously requested. 
The first hyperimmune plasma bag was administered on HD 
2 and the second one after 24 hours, with no complications. 
IgG and IgM antibodies for SARS-CoV-2 increased during 
the following days (see Table 1).
During ICU stay, the best level of positive end expiratory 
pressure (PEEP) was evaluated and set daily through PEEP 
trials. Chest radiographs had revealed bilateral multiple pa-
renchymal opacities, worse on the left lung (See Figure 1A), 
then partially improved (See Figure 1B). Lung ultrasounds 
were used for daily monitoring, to reduce the pregnant pa-
tient's exposure to ionizing radiations. Lung ultrasounds 
showed multiple confluent B lines and thickening of the 
pleura (See Figure 2A). During the entire ICU stay, the pa-
tient was visited daily by gynecologists and obstetricians in 
order to monitor the advancement of the pregnancy and the 
status of the fetus (see Figure  2B,C). Fetal well-being was 
monitored using ultrasound evaluation of active movements, 
amniotic fluid, and umbilical artery Doppler. Maternal and 
fetal monitoring was regularly performed both in the supine 
and in the prone position.
Pharmacological therapy consisted in low molecular 
weight heparin (enoxaparin sodium 4000 UI twice a day) 
to prevent thromboembolic events, betamethasone (12  mg 
daily for 2  days) to accelerate fetal lung maturity and em-
pirical antibiotic therapy with clarithromycin (500 mg twice 
a day) and ceftriaxone (2 g daily), then substituted by van-
comycin (2 g daily) because of a bronchial aspirate positive 
to Staphylococcus aureus, followed also by positive hemo-
cultures. According to the local protocol, patient's bronchial 
aspirate was weekly tested for common respiratory pathogens 
during ICU stay.
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On HD 7 weaning procedures started, neuromuscular 
blocking agents were stopped, sedation minimized and 
respiratory support gradually reduced. Progressive wean-
ing led to extubation on HD 11; thereby, the patient was 
assisted with alternated cycles of HFNC oxygen therapy 
and conventional O2 therapy. The patient was increasingly 
tachypnoic when on the night of HD 14, she was reintu-
bated. On the same day, the antibiotic therapy was modified, 
because of a bronchial aspirate positive for Pseudomonas 
aeruginosa sensitive to Meropenem (1 g × 3). The follow-
ing day the patient's bronchial aspirate came back negative 
for SARS-CoV-2.
On HD 17, at 30.1 weeks of pregnancy, due to reduced 
pulmonary compliance, and a worsening of hypoxia and 
hypercapnia, it was decided to perform a cesarean section 
and deliver the fetus. At birth, the infant was hypotonic, 
hyporeactive without autonomous respiratory activ-
ity (APGAR: 1′:3, after intubation 5′:6; 10′:7), and was 
therefore intubated and transferred to neonatal intensive 
care unit (NICU). The newborn's bronchial aspirate tested 
negative for SARS-CoV-2. On HD 18, a successful extu-
bation was performed on the newborn, followed by Nasal 
Continuous Positive Airway Pressure (nCPAP) support and 
the start of oral feeding.
The mother's postoperative course proceeded without 
complications. Chest computerized tomography (CT) was 
performed after the delivery, showing multiple, diffuse, bi-
lateral parenchymal lung thickening with consolidations and 
a ground glass pattern with thickening of pulmonary intersti-
tium. (See Figure 1C).
On HD 19, the patient's condition remained basically un-
changed, so in order to guarantee better gas exchange and 
promote weaning from mechanical ventilation, a percutane-
ous tracheostomy was performed under bronchoscopy sight, 
without complications.
Then, sedation was reduced and weaning attempted, 
with a full restoration of valid spontaneous ventilation on 
HD 23.
General conditions improved, the patient started oral feed-
ing together with passive and active physiotherapy. Chest CT 
also showed a reduction of pulmonary consolidations. (See 
Figure 1D).
On HD 32, the patient was transferred to the pneumol-
ogy ward in satisfactory general conditions. A few days 
F I G U R E  1  Chest radiographs and Computerized tomographies. The figure shows chest radiographs and chest computerized tomographies 
(CTs) at different moments. Panel A: Chest radiographs (day 3 from hospital admission) showing multiple bilateral parenchimal opacities tending 
to confluency, major on the left side. Panel B: Chest radiographs (day 38 from hospital admission) showing residual increase of bronchovascular 
markings in the basal region, more evident on the right side. Panel C: Chest CT (day 18 from hospital admission) showing multiple bilateral diffuse 
lung consolidations with ground glass aspect and thickening of lung interstitium. Panel D: Chest CT (day 28 from hospital admission) showing 
residual consolidations with fibrotic aspect in the upper lobes and diffuse thickening of lungs' interstitium with ground glass prevalent pattern
(a) (b)
(c) (d)
   | 3355DONZELLI Et aL.
later, tracheostomy cannula was removed. The patient was 
transferred to the infectious disease ward on HD 39 and 
ultimately discharged from hospital on HD 42. The pa-
tient is still undergoing periodical clinical and radiological 
follow-up.
3 |  DISCUSSION
This case described the successful maternal and perinatal 
clinical course of a pregnant patient with critical COVID-19 
after 43  days of hospitalization, including 33  days of ICU 
stay. The most relevant interventions were prone positioning 
and hyperimmune plasma therapy.
Our findings do not prove the efficacy of the interven-
tions, also considering the lack of high-quality evidence in 
this specific setting (maternal/perinatal). Moreover, many 
clinical choices may have been influenced by the specific 
context, that is, a nonoverwhelmed hospital, temporarily 
intended for the care of COVID-19 patients only. This may 
further limit the external validity of the described findings. 
Also, the decision not to perform CT scan is in contrast with 
the evidence that chest CT has become the reference imaging 
method for the diagnosis of COVID-19 pneumonia and treat-
ment follow-up. Despite the pregnant women's exposure to 
CT radiation barely reaches the dose that causes harm to the 
fetus, we preferred a more conservative approach. However, 
our case suggests the feasibility of prone positioning in preg-
nant COVID-19 patients and provides useful insights on the 
pivotal role of multidisciplinary debates on clinical choices, 
in the context of lack of evidence. As an example, it was col-
legially decided to perform preterm cesarean section only if a 
drastic worsening of the patient's condition occurred.
To date, only limited evidence is available on pregnant 
patients with COVID-19 and newborns from infected moth-
ers.16-18 Data regarding these specific populations would be 
of great interest, considering the physiological changes in 
pregnancy compared to nonpregnant women. In the case of 
mainly respiratory diseases, such as COVID-19 or previously 
pandemic viral diseases (eg, H1N1), it is important to con-
sider that a pregnant woman has an increased oxygen uptake 
and a high basal metabolism, a reduced functional residual ca-
pacity, an elevated diaphragm and airway edema, potentially 
contributing to worsen the clinical condition.19 Furthermore, 
the hypercoagulable status, typical of pregnancy, may also 
have a role in deteriorating COVID-19 into its severe or crit-
ical forms in these patients.20 No clear evidence exists on the 
determinants of severity in the context of COVID-19, and the 
clinical course is even less predictable in pregnant women, as 
an under-studied population.
Prone positioning has been proven to reduce mortality 
in ARDS,5 improving gas exchange and ventilation/per-
fusion ratio, through the recruitment of previously non-
aerated areas of the lung. Only limited evidence exists on 
prone position in pregnant women. Among the concerns 
related to prone positioning in pregnant patients, aortoca-
val compression can occur, causing severe hypotension, 
that must be avoided. Thus, the procedure becomes even 
more demanding for nurses, and fetal monitoring is also 
difficult once the patient is prone positioned.9 On the other 
F I G U R E  2  Ultrasounds. Panel A: Lung ultrasound showing 
multiple confluent B lines and pleural line thickening. Panel B: Fetal 
monitoring through umbilical artery doppler. Panel C: Fetal monitoring 
through biometrical measurements, for example, head circumference: 
showing regular fetal development
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hand, the prone position has been described as safe and 
potentially advantageous in healthy or pre-eclamptic preg-
nant patients,21,22 and recently described in pregnant pa-
tients with COVID-19.17,23,24 Despite encouraging, data 
on COVID-19 patients, both pregnant and nonpregnant, 
remain limited.
No clear evidence exists on convalescent plasma effec-
tiveness in reducing the risk of death or the need for re-
spiratory support in patients with COVID-19, and limited 
data are available on its safety.7 We registered an increase 
in the patient's antibody title after administration of hyper-
immune plasma, as documented by immunoglobulin (Ig) 
levels (Table 1). Nevertheless, the presence of antibodies 
against SARS-CoV-2 does not directly indicate protec-
tive immunity, since direct associations have not yet been 
proved,25 and no conclusions can be drawn from our case 
on the topic.
The procedure of tracheostomizing a critically ill patient 
is often a source of debate for the clinical team, especially 
on patient selection, timing, best setting, and methods. In 
the context of COVID-19 pandemic, new concerns regard 
healthcare workers' exposure to a high risk of intraprocedural 
contagion. A conservative approach is suggested, together 
with adequate protective personal equipment and appropriate 
training provided to the team 26-28 and this approach was suc-
cessfully followed in our case.
Most of the proposed pharmacological therapies for 
COVID-19 are still controversial,3,29,30 and none of them was 
administered in this case, except for empirical antibiotics, 
used with the purpose of superinfections prophylaxis. Despite 
the emerging evidence on the beneficial role of corticoste-
roids (eg, dexamethasone) in COVID-19,31 no conclusions 
can be drawn from this case on the use of betamethasone, 
administered with the purpose of preventing newborn respi-
ratory distress syndrome, as the need of a preterm delivery 
was anticipated.
The negativity of the newborn infant to SARS-CoV-2 
testing reflects what has already been described in available 
literature, reporting rare vertical transmissions.17,32
We believe that collective decisions, such as those regard-
ing prone positioning, timing of cesarean section and trache-
ostomy, positively influenced the outcome of both the mother 
and the newborn. Similarly, we believe that the close co-op-
eration with gynecologists and neonatologists, performing 
daily visits to the patient and fetal monitoring during the ICU 
stay, had relevant impact on the case. It can be argued that 
a multidisciplinary management of COVID-19 critically ill 
pregnant women is needed to ensure the best maternal and 
fetal care.
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